Find my Illumina, Inc. 401(k) plan

Illumina, Inc. is a biotechnology company founded in 1998 and based in San Diego, California. It provides products and services that focus on the analysis of genetic variation and biological function for genomic research. Illumina offers sequencing-based solutions for life sciences, biomarkers research, non-invasive clinical diagnostics, precision oncology and consumer genomics. Illumina has developed an innovative sequencing platform called Next Generation Sequencing (NGS), which has become the driving force in DNA sequencing technology as it can map statistically relevant regions of genetic variation across samples much faster than other commercially available methods. This breakthrough technology enables broad applications ranging from human disease to evolutionary biology to crop improvement. Illumina is currently recognized as the global leader in NGS technologies and holds over 6500 issued patents associated with their various products worldwide.